These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25475629)

  • 1. Need for new technologies for detection of adventitious agents in vaccines and other biological products.
    Mallet L; Gisonni-Lex L
    PDA J Pharm Sci Technol; 2014; 68(6):556-62. PubMed ID: 25475629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary of the advanced virus detection technologies users group efforts-2013.
    Duncan P
    PDA J Pharm Sci Technol; 2014; 68(6):548-51. PubMed ID: 25475627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical approach to a viral detection pipeline using existing viral and non-viral sequence resources.
    Bekkari K; Shpungin J; Thompson JR
    PDA J Pharm Sci Technol; 2014; 68(6):595-601. PubMed ID: 25475634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of adventitious agents using next-generation sequencing.
    Richards B; Cao S; Plavsic M; Pomponio R; Davies C; Mattaliano R; Madden S; Klinger K; Palermo A
    PDA J Pharm Sci Technol; 2014; 68(6):651-60. PubMed ID: 25475640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cataloguing the taxonomic origins of sequences from a heterogeneous sample using phylogenomics: applications in adventitious agent detection.
    Charlebois RL; Ng SH; Gisonni-Lex L; Mallet L
    PDA J Pharm Sci Technol; 2014; 68(6):602-18. PubMed ID: 25475635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining a sample preparation workflow for advanced virus detection and understanding sensitivity by next-generation sequencing.
    Wang CJ; Feng SF; Duncan P
    PDA J Pharm Sci Technol; 2014; 68(6):579-88. PubMed ID: 25475632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a549 as a new vaccine cell substrate: digging deeper with massively parallel sequencing.
    Shabram P; Kolman JL
    PDA J Pharm Sci Technol; 2014; 68(6):639-50. PubMed ID: 25475639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome: next-generation sequencing as a virus safety test for biotechnological products.
    Cabannes E; Hébert C; Eloit M
    PDA J Pharm Sci Technol; 2014; 68(6):631-8. PubMed ID: 25475638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary Evaluation of Next-Generation Sequencing Performance Relative to qPCR and In Vitro Cell Culture Tests for Human Cytomegalovirus.
    Ng SH; Azizi A; Edamura K; Malott RJ; Charlebois RL; Logvinoff C; Schreiber M; Mallet L; Gisonni-Lex L
    PDA J Pharm Sci Technol; 2014; 68(6):563-71. PubMed ID: 25475630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New technologies and challenges of novel virus detection.
    Khan AS; Ma H; Taliaferro LP; Galvin TA; Shaheduzzaman S
    PDA J Pharm Sci Technol; 2014; 68(6):661-6. PubMed ID: 25475641
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    MacDonald ML; Polson SW; Lee KH
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33883263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling an approach to define sensitivity of viral detection in sample matrices-examples with microarray readout.
    Feng SF; Jaing C; Thissen JB; Wang C; Duncan P
    PDA J Pharm Sci Technol; 2014; 68(6):589-94. PubMed ID: 25475633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel evaluation of broad virus detection methods.
    Modrof J; Berting A; Kreil TR
    PDA J Pharm Sci Technol; 2014; 68(6):572-8. PubMed ID: 25475631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of PCR-based assays for the detection of the adventitious agent porcine circovirus type 1 (PCV1) in vaccines, and for confirming the identity of cell substrates and viruses used in vaccine production.
    Kumar D; Beach NM; Meng XJ; Hegde NR
    J Virol Methods; 2012 Jan; 179(1):201-11. PubMed ID: 22079617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of the adventitious agents in the evaluation of vaccine safety].
    Augustynowicz E; Lutyńska A
    Przegl Epidemiol; 2012; 66(4):643-9. PubMed ID: 23484394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of approaches to viral safety issues for biological products.
    Lubiniecki AS
    PDA J Pharm Sci Technol; 2011; 65(6):547-56. PubMed ID: 22294576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of the second international conference on next generation sequencing for adventitious virus detection in biologics for humans and animals.
    Khan AS; Blümel J; Deforce D; Gruber MF; Jungbäck C; Knezevic I; Mallet L; Mackay D; Matthijnssens J; O'Leary M; Theuns S; Victoria J; Neels P
    Biologicals; 2020 Sep; 67():94-111. PubMed ID: 32660862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current testing methods and challenges for detection of adventitious viruses.
    Khan AS
    PDA J Pharm Sci Technol; 2011; 65(6):627-33. PubMed ID: 22294589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing.
    Mee ET; Preston MD; Minor PD; Schepelmann S;
    Vaccine; 2016 Apr; 34(17):2035-43. PubMed ID: 26709640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products.
    Gombold J; Karakasidis S; Niksa P; Podczasy J; Neumann K; Richardson J; Sane N; Johnson-Leva R; Randolph V; Sadoff J; Minor P; Schmidt A; Duncan P; Sheets RL
    Vaccine; 2014 May; 32(24):2916-26. PubMed ID: 24681273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.